F9 and hemophilia: It is now >35 years since the cloning of the FVIII and FIX genes, and, during this time, major advances have been made in the application of molecular genetic knowledge to hemophilia diagnostic testing and in the generation of novel bioengineered recombinant clotting factor concentrates.